Promoting Exclusive Breastfeeding Among HIV Infected Women in a PMTCT Program
NCT ID: NCT03069235
Last Updated: 2017-03-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
218 participants
INTERVENTIONAL
2012-02-08
2013-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Text Messaging Plus Motivational Interviewing in Promotion of Breastfeeding Among HIV-infected Women
NCT02949713
PROMISE EBF: Safety and Efficacy of Exclusive Breastfeeding Promotion in the Era of HIV in Sub-Saharan Africa
NCT00397150
Mobile Phone Text Messaging Plus Motivational Interviewing: Effects on Breastfeeding, Child Health Outcomes
NCT05063240
DarDar Nutrition Study in HIV Breastfeeding Women
NCT01461863
Breast for Success: A Family-Centered Intervention in Support of Breastfeeding Among High-risk Low-income Mothers
NCT01272661
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary objective of the qualitative formative research which includes Focus Group Discussions (FGD) and Key Informant Interviews (KII) is to explore factors affecting decisions on EBF and continued breastfeeding among HIV infected women.
The primary objective for the Intervention phase is to compare either of two intervention strategies against the standard arm using Ministry of Health (MOH) messages aimed at promoting EBF for 6 month.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard of Care
group/individual counselling.
standard of care
one on one and in-group counselling
Family member / peer support
Structured family member / peer support.
Family member / peer support
supplemental individualized counselling
Special infant feeding counselor support
Enhanced intervention with counselor support
Family member / peer support
supplemental individualized counselling
Enhanced intervention with counselor support
"hands on" EBF demonstrations
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Family member / peer support
supplemental individualized counselling
Enhanced intervention with counselor support
"hands on" EBF demonstrations
standard of care
one on one and in-group counselling
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* On antiretroviral therapy (ARVs) for PMTCT or meets MOH guidelines for ARV therapy
* Intention to breast feed
* Willingness to deliver at Mulago Hospital
* Living within Kampala and planning to stay within Kampala district for months after delivery
* Willingness to participate during post partum period
* Willingness to be home visited
* Willingness and ability to bring a close family member of choice to the clinic, who is ≥ 18 years, who will be able to be in touch with the at least three times a week and to give support on EBF
Exclusion Criteria
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MU-JHU CARE
OTHER
Johns Hopkins University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joyce Matovu, MA
Role: PRINCIPAL_INVESTIGATOR
MU-JHU CARE
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NA_00050616
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.